TRADING UPDATES: Valereum invests in Blubird; Hemogenyx raises funds
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Price | 7.50p on 08-08-2025 | at 13:00:24
---|---|
Change | 0.00p 0% |
Buy | 8.00p |
Sell | 7.00p |
Last Trade: | Sell 10,400.00 at 7.3473p |
Day's Volume: | 10,437 |
Last Close: | 7.50p |
Open: | 7.50p |
ISIN: | GB00BYWL4Y04 |
Day's Range | 7.50p - 7.50p |
52wk Range: | 6.50p - 14.50p |
Market Capitalisation: | £24.84m |
VWAP: | 7.349614p |
Shares in Issue: | 331.21m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Renalytix Plc (RENX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 10,400 | 7.3473p | Ordinary |
11:11:04 - 08-Aug-25 |
Buy* | 37 | 8.00p | Ordinary |
08:31:12 - 08-Aug-25 |
Sell* | 4 | 7.00p | Ordinary |
15:37:45 - 07-Aug-25 |
Sell* | 631 | 7.3623p | Ordinary |
11:57:50 - 07-Aug-25 |
Sell* | 20,386 | 7.10p | Ordinary |
11:33:05 - 07-Aug-25 |
Sell* | 10,135 | 7.40p | Ordinary |
09:25:56 - 07-Aug-25 |
Sell* | 50,000 | 7.2275p | Ordinary |
08:43:47 - 07-Aug-25 |
Unknown* | 2,593 | 7.50p | Negotiated Trade |
16:25:09 - 06-Aug-25 |
Unknown* | 3,393 | 7.50p | Ordinary |
16:24:37 - 06-Aug-25 |
Sell* | 50 | 7.2275p | Ordinary |
10:09:08 - 06-Aug-25 |
Renalytix Plc (RENX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
29th Jul 2025 7:00 am | RNS | Services contract with Joslin and Pharma Partner |
17th Jul 2025 7:01 am | RNS | Partnership with MVP Health Care |
17th Jul 2025 7:00 am | RNS | Change of Adviser |
27th Jun 2025 1:09 pm | RNS | Holding(s) in Company |
26th Jun 2025 11:48 am | RNS | Holding(s) in Company |
17th Jun 2025 7:00 am | RNS | kidneyintelX.dkd data presented at ERA Congress |
3rd Jun 2025 7:00 am | RNS | Growing collaboration with NYKHM |
30th May 2025 12:38 pm | RNS | Holding(s) in Company |
29th May 2025 12:35 pm | RNS | Holding(s) in Company |
27th May 2025 12:43 pm | RNS | Holding(s) in Company |